Depression and anxiety among psoriasis patients

Hojat Eftekhari; Robabeh Soleimani; Saba Mostafavi; Fatemeh Eslamdoust-Siahestalkhi; Sara Yeganeh

doi:10.5114/dr.2024.142135

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

3/2024
vol. 111

Send email

Copy url:

abstract:

Original article

Depression and anxiety among psoriasis patients

Hojat Eftekhari

¹

,

Robabeh Soleimani

²

,

Saba Mostafavi

³

,

Fatemeh Eslamdoust-Siahestalkhi

²

,

Sara Yeganeh

⁴

Skin Research Center, Department of Dermatology, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Kavosh Cognitive Behavior Sciences and Addiction Research Center, Department of Psychiatry, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Department of Dermatology, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

Dermatol Rev/Przegl Dermatol 2024, 111, 191-197

DOI: https://doi.org/10.5114/dr.2024.142135

Online publish date: 2024/11/08

View full text Get citation

PlumX metrics:

Introduction:
Psoriasis is a chronic and non-contagious skin disease. Patients with psoriasis might experience many mental disorders that affect all aspects of the patient's life.

Objective:
To investigate the prevalence of depression and anxiety among patients with psoriasis.

Material and methods:
This was a cross-sectional descriptive study on 149 psoriasis patients who were referred to the dermatology clinic in 2021. Questionnaires, including demographics, Beck Anxiety Inventory (BAI), Beck Depression Inventory-II (BDI-II), and Psoriasis Area Severity Index (PASI), were used. The data were analyzed using IBM SPSS Statistics version 28. The level of significance was set at 0.05.

Results:
In this study the mean age was 40.30 ±10.38 years. The female population was 59.7%. It was observed that 25.5%, 47%, and 27.5% of participants had mild, moderate, and severe psoriasis, respectively. Furthermore, 23.5% of the participants reported some degree of depression, and 36% had some degree of anxiety. The frequency of depression was significantly higher in people with comorbidities (p = 0.001). The severity of depression and anxiety had a significant relationship with each other (r = 0.3, p < 0.001).

Conclusions:
There was no link between depression and anxiety with psoriasis in our study. We suggest more studies should be done with a larger sample size.

keywords:

Depression and anxiety among psoriasis patients

Hojat Eftekhari 1 , Robabeh Soleimani 2 , Saba Mostafavi 3 , Fatemeh Eslamdoust-Siahestalkhi 2 , Sara Yeganeh 4

psoriasis, depression, anxiety

Hojat Eftekhari

¹

,

Robabeh Soleimani

²

,

Saba Mostafavi

³

,

Fatemeh Eslamdoust-Siahestalkhi

²

,

Sara Yeganeh

⁴